Program

Program at a Glance

Shirotori Hall (A)

 Shirotori Hall B (Poster Session)

Symporium Program

Thursday, May 12, 2011

SYMPOSIUM 1.  UREMIC TOXINS UPDATE 1

Toshimitsu Niwa (Japan)
Indoxyl sulfate induces nephro-vascular senescence

Shaul G. Massry (USA)
PTH receptor is present in many tissues and is down regulatedby CKD

Boleslaw Rutkowski (Poland)
Cellular toxicity of purine nucleotides

Raymond Vanholder (Belgium)
What is new in the world of protein bound uremic toxins

LECTURE 1
Shunya Uchida (Japan)
Uric acid as an old but new uremic toxin

SYMPOSIUM 2. UREMIC TOXINS UPDATE 2

Masaomi Nangaku (Japan)
Dysregulated oxygen metabolism of the kidney by uremic toxins

Masafumi Fukagawa (Japan)
Roles of uremic toxins and oxidative stress in the development of CKD-MBD

Timothy Meyer (USA)
Removal of protein bound uremic toxins

Guido Bellinghieri (Italy)
Role of advanced oxidation protein product in diabetic patients with end stage kidney disease

Paul J. Thornalley (UK)
Dicarbonyl glucose degradation products and advanced glycation endproducts (AGEs) in uremia - the damage caused and strategies to prevent it

Monika Pischetsrieder (Germany)
New aspects on glucose degradation products in peritoneal dialysis

Friday, May 13, 2011

SYMPOSIUM 3. MUSCLE AND NERVOUS SYSTEM IN CKD

William E. Mitch (USA)
Uremic toxicity blocks both protein metabolism and satellite cell function in muscles

Vladimir Teplan (Czech Republic)
Muscle and fat metabolism after kidney transplantation

Gianfranco Guarnieri (Italy)
Ghrelin and muscle metabolism in chronic uremia

Katarina Sebekova (Slovakia)
Effect of experimental chronic renal insufficiency (CRI) on the neuronal activity in certain brain areas of rats

Joel D. Kopple (USA)
Anxiety, depression in chronic kidney failure: Prevalence, mechanisms and racial/ethnic disparities

LECTURE2
Takashi Wada (Japan)
Inflammatory process in the progression of kidney disease

LECTURE3
Eiji Kusano (Japan)
Fabry disease screening study for hemodialysis patients

SYMPOSIUM 4. CARDIOVASCULAR DISEASE IN CKD

Sudhir Shah (USA)
Novel concepts in understanding accelerated atherosclerosis in                                                chronic kidney disease

Ziad A. Massy (France)
New insights on vascular calcifications

Yoshiki Nishizawa (Japan)
Cardiovascular complications in CKD: Implications of advanced glycation end-products and their receptor, RAGE

Bengt Lindholm (Sweden)
Novel cardiovascular disease biomarkers in CKD

Miroslaw Smogorzewski (USA)
Predictors of progression of kidney disease in hypertensive                                                      nephropathy: Lessons from the AASK study

Liliana Garneata (Romania)
The intervention of iron in the relationship between CKD, congestive heart failure and anemia

Saturday, May 14, 2011

SYMPOSIUM 5. ORGAN DYSFUNCTION IN CKD

Nosratola D. Vaziri (USA)
Impact of uremia on immune function and structure

Daniel Teta (Switzerland)
Adipokines as uremic toxins

Yahya Sagliker (Turkey)
Clinical, cytogenetical and genetical studies: Evaluation of 1, 3, 4, 5, 7, 10 and 13th exons of GNAS 1 gene, and  2nd and 3rd exons of CaSR gene in Sagliker syndrome; Uglifying human face appearances in severe and late CKD patients

Marian Klinger (Poland)
New onset post transplant diabetes mellitus begins in the dialysis period

Nathan Levin (USA)
Intradialytic calcium balance

LECTURE4
Yukio Yuzawa (Japan)
Cross-talk between kidney and lung in critical care nephrology

LECTURE5
Toshiyuki Nakao (Japan)
A new insight into low protein diets for chronic kidney failure

SYMPOSIUM 6. THERAPEUTIC STRATEGIES FOR CKD

Gerald Schulman (USA)
Assessing treatment strategies to prevent progression of CKD

Alessandra Perna (Italy)
N-Acetylcysteine in the therapy of hyperhomocysteinemia of chronic                                           kidney failure

Takashi Akiba (Japan)
Uric acid, allopurinol, and mortality in CKD stage 5D

Vincenzo Savica (Italy)
The carnitine system: A global approach to hemodialysed patients

Natale G. De Santo (Italy)
Survival is not enough: Quality of life in CKD

Topics
The scientific program will include symposium lectures, free communications and poster sessions on all aspects of uremia research and toxicity.

Uremic Toxins
Cellular and Molecular Derangements
Progression of CKD
Hypertension
Cardiovascular Disease (CKD-CVD)
Renal Anemia and Iron Metabolism
Mineral and Bone Disorder (CKD-MBD)
Inflammation and Oxidative Stress
Immune Dysfunction
Miscellaneous Uremic Complications
Nutrition and Metabolism
Dialysis Therapy (HD, HDF, HF, PD, etc.)
Renal Transplantation

 

Invited Speakers (not conclusive)

Guido Bellinghieri (Italy)
Natale G. De Santo (Italy)
Liliana Garneata (Roumania)
Gianfranco Guarnieri (Italy)
Marian Klinger (Poland)
Joel D. Kopple (USA)
Nathan Levin (USA)
Bengt Lindholm (Sweden)
Shaul G. Massry (USA)
Ziad A. Massy (France)
Timothy Meyer (USA)
William E. Mitch (USA)
Alessandra Perna (Italy)
Monika Pischetsrieder (Germany)
Boleslaw Rutkowski (Poland)
Yahya Sagliker (Turkey)
Vincenzo Savica (Italy)
Gerald Schulman (USA)
Katarina Sebekova (Slovakia)
Sudhir Shah (USA)
Miroslaw Smogorzewski (USA)
Vladimir Teplan (Czech Republic)
Daniel Teta (Switzerland)
Paul J. Thornalley (UK)
Raymond Vanholder (Belgium)
Nosratola D. Vaziri (USA)